SIRNAOMICS-B News

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS RECEIVED FDA SPECIFIC GUIDANCE FOR FURTHER DEVELOPMENT OF STP705 FOR TREATMENT OF SQUAMOUS CELL CARCINOMA IN SITU

Apr 16 10:28 ET

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 5 04:31 ET

SIRNAOMICS-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023

Mar 27 10:45 ET

SIRNAOMICS-B: INSIDE INFORMATION

Mar 17 18:05 ET

SIRNAOMICS-B: NOTICE OF BOARD MEETING

Mar 13 06:21 ET

SIRNAOMICS-B: ANNOUNCEMENT IN RELATION TO DEALINGS IN SECURITIES OF A DIRECTOR DURING THE BLACK-OUT PERIOD

Mar 7 09:38 ET

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 5 03:31 ET

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - UNUSUAL SHARE PRICE MOVEMENT

Feb 29 07:16 ET

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 5 03:36 ET

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 04:58 ET

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - RNAIMMUNE RECEIVES INVESTIGATIONAL NEW DRUG APPLICATION CLEARANCE FROM U.S. FDA FOR mRNA-BASED RESPIRATORY SYNCYTIAL VIRUS VACCINE RV-1770

Dec 18, 2023 06:54 ET

SIRNAOMICS-B: CONNECTED TRANSACTION - GRANT OF STOCK OPTIONS BY A SUBSIDIARY TO A CONNECTED PERSON

Dec 6, 2023 09:51 ET

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES SUCCESSFUL COMPLETION OF COHORT 1 FROM PHASE I CLINICAL STUDY OF GALNAC-BASED RNAi THERAPEUTIC STP122G FOR ANTICOAGULANT TREATMENT

Dec 5, 2023 09:21 ET

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 03:53 ET

SIRNAOMICS-B: GRANT OF SHARE OPTIONS

Nov 30, 2023 09:55 ET

SIRNAOMICS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Nov 30, 2023 09:53 ET

SIRNAOMICS-B: RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGES TO SENIOR MANAGEMENT

Nov 30, 2023 09:47 ET

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 3, 2023 04:50 ET

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS PRESENTS POSITIVE CLINICAL DATA OF STP705 FOR FOCAL FAT REDUCTION

Nov 1, 2023 06:46 ET

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 5, 2023 04:34 ET